Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature
about
Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry diseaseAngiokeratomas of Fabry successfully treated with intense pulsed light.Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?High throughput screening for inhibitors of alpha-galactosidase.Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapyMulti-system disorders of glycosphingolipid and ganglioside metabolismFabry disease - current treatment and new drug development.Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®)).Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry diseaseUpdate on role of agalsidase alfa in management of Fabry disease.Ocular signs correlate well with disease severity and genotype in Fabry disease.Gene therapy for neurologic manifestations of mucopolysaccharidoses.Lentivector transduction improves outcomes over transplantation of human HSCs alone in NOD/SCID/Fabry mice.Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis.Agalsidase alfa (Replagal) in the treatment of Anderson-Fabry diseaseSynthesis and characterization of a new fluorogenic substrate for alpha-galactosidase.Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal).Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha.Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy.Fabry disease and Factor V Leiden: a potent vascular risk combination.Modelling the resource implications of managing adults with Fabry disease in Italy.
P2860
Q28748170-3630F921-0661-4E88-8D1C-D99B10D56D90Q33373387-B4337863-FE28-450B-A2BF-85D465B9BFDEQ33645550-5B646B51-CD3C-4B4B-B856-9E12D12924ABQ33823628-B5BA4BE7-AB50-453D-B2BC-8280045CEF71Q33847189-2D259C3C-3844-4004-92CF-7CCB88C6854DQ33902037-74C80103-34C8-4853-A8B8-8C2F8EC4763EQ34368512-820B4879-81E2-4341-8E79-3AC9ADC43FD3Q34734676-7E96E265-1291-4C74-84C2-E68DADA6B84BQ34794444-B1EBFF3A-933C-444C-97E8-D5BF1AF38DB9Q34883178-962EC79C-9DE9-48FD-97F7-8C9C0D8EB386Q35187827-068A3353-CE2A-4479-B470-F005DE97FA61Q35362251-D2633E16-7CEE-4992-9F54-F5ED403103A5Q36087322-A0B2D264-3FA7-4AA9-98F5-5EBE93481280Q36607211-258C1E49-A4C1-494C-A390-F9E0147DB0A4Q37290507-09860417-1313-42F6-B77E-C9750C406D01Q37373742-F403782E-67C6-49B8-9A6F-1AFF2A9C3E01Q37536880-6D14CDEA-8A72-4AD6-9C46-B8DC3EE54524Q37591813-995C01FB-AD03-4832-BA0D-D87346E04B42Q40355885-2A63722B-FC3B-40F9-A330-12EF5E149083Q46587509-FAF421F9-54A4-42A4-8894-EF303892DBB0Q48664517-0BF041D2-BA47-4BB9-BC13-9DBCAED59783Q51158499-A1E6F84E-4A5D-425C-AD6B-0E42615176F0
P2860
Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical results of enzyme rep ...... rehensive review of literature
@ast
Clinical results of enzyme rep ...... rehensive review of literature
@en
Clinical results of enzyme rep ...... rehensive review of literature
@nl
type
label
Clinical results of enzyme rep ...... rehensive review of literature
@ast
Clinical results of enzyme rep ...... rehensive review of literature
@en
Clinical results of enzyme rep ...... rehensive review of literature
@nl
prefLabel
Clinical results of enzyme rep ...... rehensive review of literature
@ast
Clinical results of enzyme rep ...... rehensive review of literature
@en
Clinical results of enzyme rep ...... rehensive review of literature
@nl
P2093
P2860
P1476
Clinical results of enzyme rep ...... rehensive review of literature
@en
P2093
J-F Alexandra
R Jaussaud
P2860
P304
P356
10.1111/J.1742-1241.2006.01237.X
P407
P577
2007-02-01T00:00:00Z